Table 1 Baseline characteristics of patients hospitalized on RIHU and registered in ONKO-KISS from July 2003 through December 2012
From: Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
Total number of patients | 753 |
Males | 458 (60.8%) |
Females | 295 (39.2%) |
Median age in years | Â |
Males | 49 (38–61 IQR) |
Females | 50 (38–59 IQR) |
Underlying conditions: | Â |
Acute myeloid leukaemia | 304 (40.4%) |
Acute lymphatic leukaemia | 97 (12.9%) |
Myelodysplastic syndrome | 47 (6.2%) |
Non-Hodgkin lymphoma | 70 (9.3%) |
Plasma cell disorders | 83 (11%) |
Underlying condition not in records | 1 (0.1%) |
Treatment regimens: | Â |
Number of allogeneic HSCT recipients: | 440 |
PBSC recipients | 412 (93.6%) |
BMT recipients | 25 (5.7%) |
Cord blood recipients | 3 (0.7%) |
Donor related/unrelated | 242/198 (55.0%/45.0%) |
Number of autologous HSCT recipients: | 172 |
Number of patients undergoing induction, re-induction or conditioning chemotherapy: | 123 |
Other chemotherapies (consolidation chemotherapy, or treatment not specified in database) | 16 |